vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Pattern Group Inc. (PTRN). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $639.7M, roughly 1.5× Pattern Group Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -9.2%, a 9.9% gap on every dollar of revenue. Pattern Group Inc. produced more free cash flow last quarter ($75.7M vs $-6.0M).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Pattern Energy Group LP is an American company that develops, owns and operates utility scale wind and solar power facilities in the United States, Canada, and Mexico. It is headquartered in San Francisco, California with an operations center in Houston, Texas.

ASTH vs PTRN — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.5× larger
ASTH
$950.5M
$639.7M
PTRN
Higher net margin
ASTH
ASTH
9.9% more per $
ASTH
0.7%
-9.2%
PTRN
More free cash flow
PTRN
PTRN
$81.7M more FCF
PTRN
$75.7M
$-6.0M
ASTH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASTH
ASTH
PTRN
PTRN
Revenue
$950.5M
$639.7M
Net Profit
$6.6M
$-59.1M
Gross Margin
44.3%
Operating Margin
1.9%
-9.4%
Net Margin
0.7%
-9.2%
Revenue YoY
42.9%
Net Profit YoY
184.4%
EPS (diluted)
$0.12
$-2.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
PTRN
PTRN
Q4 25
$950.5M
Q3 25
$956.0M
$639.7M
Q2 25
$654.8M
Q1 25
$620.4M
Q4 24
$665.2M
Q3 24
$478.7M
Q2 24
$486.3M
Q1 24
$404.4M
Net Profit
ASTH
ASTH
PTRN
PTRN
Q4 25
$6.6M
Q3 25
$373.0K
$-59.1M
Q2 25
$9.4M
Q1 25
$6.7M
Q4 24
$-7.8M
Q3 24
$16.1M
Q2 24
$19.2M
Q1 24
$14.8M
Gross Margin
ASTH
ASTH
PTRN
PTRN
Q4 25
Q3 25
44.3%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ASTH
ASTH
PTRN
PTRN
Q4 25
1.9%
Q3 25
2.0%
-9.4%
Q2 25
3.1%
Q1 25
3.3%
Q4 24
0.1%
Q3 24
5.9%
Q2 24
6.2%
Q1 24
7.5%
Net Margin
ASTH
ASTH
PTRN
PTRN
Q4 25
0.7%
Q3 25
0.0%
-9.2%
Q2 25
1.4%
Q1 25
1.1%
Q4 24
-1.2%
Q3 24
3.4%
Q2 24
3.9%
Q1 24
3.7%
EPS (diluted)
ASTH
ASTH
PTRN
PTRN
Q4 25
$0.12
Q3 25
$0.01
$-2.19
Q2 25
$0.19
Q1 25
$0.14
Q4 24
$-0.14
Q3 24
$0.33
Q2 24
$0.40
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
PTRN
PTRN
Cash + ST InvestmentsLiquidity on hand
$429.5M
$312.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$541.4M
Total Assets
$2.2B
$843.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
PTRN
PTRN
Q4 25
$429.5M
Q3 25
$463.4M
$312.8M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Q1 24
$337.3M
Stockholders' Equity
ASTH
ASTH
PTRN
PTRN
Q4 25
$779.3M
Q3 25
$775.5M
$541.4M
Q2 25
$765.5M
Q1 25
$745.4M
Q4 24
$712.7M
Q3 24
$704.6M
Q2 24
$678.9M
Q1 24
$653.5M
Total Assets
ASTH
ASTH
PTRN
PTRN
Q4 25
$2.2B
Q3 25
$2.2B
$843.1M
Q2 25
$1.4B
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
PTRN
PTRN
Operating Cash FlowLast quarter
$-2.9M
$90.9M
Free Cash FlowOCF − Capex
$-6.0M
$75.7M
FCF MarginFCF / Revenue
-0.6%
11.8%
Capex IntensityCapex / Revenue
0.3%
2.4%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
PTRN
PTRN
Q4 25
$-2.9M
Q3 25
$10.0M
$90.9M
Q2 25
$90.9M
Q1 25
$16.6M
Q4 24
$-10.9M
Q3 24
$34.0M
Q2 24
$23.2M
Q1 24
$6.0M
Free Cash Flow
ASTH
ASTH
PTRN
PTRN
Q4 25
$-6.0M
Q3 25
$7.4M
$75.7M
Q2 25
$89.5M
Q1 25
$13.6M
Q4 24
$-13.5M
Q3 24
$31.7M
Q2 24
$20.4M
Q1 24
$5.6M
FCF Margin
ASTH
ASTH
PTRN
PTRN
Q4 25
-0.6%
Q3 25
0.8%
11.8%
Q2 25
13.7%
Q1 25
2.2%
Q4 24
-2.0%
Q3 24
6.6%
Q2 24
4.2%
Q1 24
1.4%
Capex Intensity
ASTH
ASTH
PTRN
PTRN
Q4 25
0.3%
Q3 25
0.3%
2.4%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
0.6%
Q1 24
0.1%
Cash Conversion
ASTH
ASTH
PTRN
PTRN
Q4 25
-0.44×
Q3 25
26.69×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

PTRN
PTRN

Amazon.com$549.2M86%
Amazon Marketplaces International$43.4M7%
Other Online Marketplaces And Channels$39.4M6%
Saa S Logistics And Other Revenue$7.7M1%

Related Comparisons